%D9%83%D9%84%D9%8A%D8%A9_%D8%B7%D8%A8_%D9%86%D9%8A%D9%88%D9%8A%D9%88%D8%B1%D9%83%D9%86%DB%8C%D9%88%DB%8C%D9%88%D8%B1%DA%A9_%D8%B7%DB%8C%D8%A8_%DA%A9%D8%A7%D9%84%D8%AC%DB%8CNew_York_Medical_College%DA%A9%D8%A7%D9%84%D8%AC_%D9%BE%D8%B2%D8%B4%DA%A9%DB%8C_%D9%86%DB%8C%D9%88%DB%8C%D9%88%D8%B1%DA%A9%E3%83%8B%E3%83%A5%E3%83%BC%E3%83%A8%E3%83%BC%E3%82%AF%E5%8C%BB%E7%A7%91%E5%A4%A7%E5%AD%A6Q4115972%E7%BA%BD%E7%BA%A6%E5%8C%BB%E5%AD%A6%E9%99%A2
about
William Ward PigmanStella ChessZbyszek DarzynkiewiczEliana ScemesBoris KrasnikovYodo SugishitaSusan S WallaceMarie AscherNoah KauffElangovan SelvakumarGiacomo SignorinoAvedis DonabedianPaul A. LucasDumitru A. IacobasMiguel ArosoHelen Margaret WallaceVictor GarciaAlice Mary StollYujiao ZhaoAnna SedivaZhongtao ZhangPaul M ArnaboldiSini SkariahKeosha T BondEnes TaylanIman DoostanErcüment DiriceTetyana KobetsFrances ReiterHorace GreenAndrew T Del PozziTanush GuptaZEEV RONAIR B MarkowitzZ Y ZhouR GoldbergMarvin S. MedowDavid A MoskowitzDhara PatelHong Peng
P108
Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent OsteosarcomaVaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyProvenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone TherapyCombination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk RhabdomyosarcomaBlinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic LeukemiaEfficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary EmbolismSafety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic LeukemiaDonor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other DiseasesEfficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host DiseaseA Study of Dasatinib vs. High-Dose Imatinib (600 mg) in Patients With Chronic Phase Chronic Myeloid Leukemia (CML) Who Failed to Achieve Complete Cytogenetic Response After 3-18 Months of Imatinib TherapyMaintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed EpendymomaHaplo T-Cell Depleted Transplantation in High-Risk Sickle Cell DiseaseAssessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First RemissionPediatric Philadelphia Positive Acute Lymphoblastic LeukemiaACY-1215 (Ricolinostat) in Combination With Pomalidomide and Low-dose Dex in Relapsed-and-Refractory Multiple MyelomaSargramostim and/or Vaccine Therapy in Preventing Disease Recurrence in Patients With Advanced MelanomaVelcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and PrednisoneStudy Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins LymphomaAST-120 Used to Treat Mild Hepatic EncephalopathyINDUCTION CHEMO-IMMUNOTHERAPY FOLLOWED BY CONSOLIDATION WITH REDUCED TOXICITY CONDITIONING AND ALLOGENEIC STEM CELL TRANSPLANT IN ADVANCED STAGE MATURE NON-ANAPLASTIC T-CELL OR NK LYMPHOMA/LEUKEMIA IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTSStudy of TPI 287 in Patients With Advanced MalignanciesCytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid LeukemiaTopotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem GliomaTreating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin DiseaseCombination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaBrachytherapy in Treating Patients With Prostate CancerDNA Variations in the Gene in Young Patients With Wilms' TumorHigh-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast CancerRadiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma MultiformeComparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk MedulloblastomaCombination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone TherapyInterleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid LeukemiaStudy of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma MultiformeRadiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck CancerRadiation Therapy in Treating Patients With Stage II or Stage III Prostate CancerPaclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagushu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory NeuroblastomaGenetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer SurvivorsDoxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple MyelomaLong-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
P6153
Kin YameiMyra Adele LoganGerald EpsteinEmily StoweMaurice M. BlackHarold KaplanWilliam L. LoveMorton BirnbaumJoel KupersmithJohn S. MarrJoseph CochranPatricia HymansonGilbert Lafayette FosterFahim RahimNaeem RahimJohn F. McDermottLucille Norville PerezAdil HaiderHarriet Jemima Winifred ClisbyLucy OzarinGeraldine BranchElizabeth JaffeeM. Belle BrownHarry J. BunckeJennie de la Montagnie LozierLurana W. SheldonArmand NicholiSusan McKinney StewardBarry S LeitmanChris ZoisClarence Sumner JaniferCornelia Chase BrantHeidi BrooksDan K. MorhaimThomas M. DeBerardinoPaul K. BenedictEdwin Hamilton DavisMarie NyswanderGary OnikGuy Beckley Stearns
P69
Q11205572-543008AB-748F-4157-90F5-11C5D9C3EC43Q28059127-a40f27ee-473b-a98e-5e1c-a6ac3d671d3eQ33103772-64C71022-D910-443C-A579-5EEB337C872AQ38328617-381856D7-3D77-4343-98DD-F2CD0ED43051Q38589883-8DD70A90-AB2A-4BAB-BAF4-C54D56D30CA3Q39067042-A4FFF69C-4CE5-4D8B-A20A-694DB36FCFD7Q41886664-60CCE3A7-8DF0-4397-B19D-59A7B1D164B9Q42842799-B4F9A42F-482E-4DFF-8B1C-DD2ED68CD0ADQ42873708-D8CEC30E-F8CF-4D7F-9185-CE6593F04A9AQ46641522-C51E3FCA-AC4F-44F0-AC9B-D1D475F0F4F1Q47402666-EE097AE5-2229-4BD4-84AC-7C74F754477CQ4827968-4ad77141-44bd-cdf5-8320-f7e506814f2dQ51724804-85D60FFD-FD1C-4D5D-AFD0-FAE08F9D6000Q52008971-496F712F-FD4B-46C9-A045-1DB600F9D015Q55426453-5E6F4D3B-E749-45BE-BD16-8E311F799E16Q55642771-7ea570a5-4bb9-58c3-2553-81ce1fd1e66dQ55965580-17EB09E8-4D9D-49D3-A65E-79F984AABF70Q56257296-e57a5676-4f4f-7de9-78b2-a2c073ffd362Q56424637-BEF72B67-CB4F-4085-91A3-1E2AAC779A2DQ56458839-F9227F31-0E10-4446-8D85-63E8A198ED95Q56956221-524AF925-9714-4E53-B38A-4F8C8B32C0B1Q56986081-2944BE85-9CDE-41B3-9281-F58527D6ACFBQ57013046-F5A5A8CA-16D5-4BF1-8C6E-F9E8D03498B3Q57014444-E5F4E8C4-B6D6-486D-B806-AB4F9ACD4324Q57561340-5E751932-F093-44D2-9CA4-6A3B82B37970Q57764232-8212E089-AA60-4A08-900B-4F72582B3599Q58442881-596BEB85-4FBB-4511-BA00-785AFC65038EQ59995330-F8DCB05E-6028-45AA-855C-582AB9364BCAQ61054175-6873cbec-4dd2-f3e8-b424-e4ab8b578342Q63170381-2D49C2CF-5816-403A-B6AB-076E0893D314Q64159890-CE49E83C-00CC-40ED-8833-B89EFBB4FADFQ64358220-1808D271-5EC9-4C89-BC8C-C5766BBFAC44Q64863785-D8861D4C-E1B8-4F9A-9688-AAC739D5FB60Q64863785-E6B2B1F9-5C94-4ADA-BB55-81FACE53559AQ72566587-45CA611D-524E-4532-A35D-76BCE096EE21Q77781819-3EDC4413-DE67-40DD-857C-97C906F2B5CEQ78106876-CF4C7AF4-7846-4651-9729-616247069643Q79244922-42beb5e4-45b4-1865-686a-9238a130e7d9Q80571992-CA867FEA-06E7-4DCE-AD87-34D160932CC9Q82297181-ED9F7B67-2CEA-4A3B-8CD2-9853D7B818DB
P108
Q14705842-B84BAEDA-87D3-42F8-A2E2-FCFB9680494BQ14706949-14295ADD-A5E7-409A-BC28-1E08C11DF2D9Q17020173-2D26DC2D-A803-4DBE-939E-4D74EC70CF1DQ4874576-73E5E2DB-2834-42C2-BE35-2D93DF2C007DQ4974388-5A425124-C845-4110-8FD9-9F1DC7261CD4Q5364917-d8533c0e-4a72-8947-21e5-3803557c516fQ7402270-24DB1B73-3705-4415-BED0-6B576F15EE74Q7589200-915C5AB0-E09C-44B7-9AAC-33D1122ADB7EQ7592067-8F6965C4-BA12-4E66-A77A-6FAD2699A647Q7987259-CFD17088-0258-4E2F-B835-D3F233E4F1D0
P1416
description
medische faculteit in de Verenigde Staten
@nl
name
Coleg Meddygol Efrog Newydd
@cy
New York Medical College
@en
New York Medical College
@fr
New York Medical College
@sv
Նյու Յորքի բժշկական քոլեջ
@hy
كلية طب نيويورك
@ar
نیویورک طیب کالجی
@azb
کالج پزشکی نیویورک
@fa
ニューヨーク医科大学
@ja
纽约医学院
@zh
type
label
Coleg Meddygol Efrog Newydd
@cy
New York Medical College
@en
New York Medical College
@fr
New York Medical College
@sv
Նյու Յորքի բժշկական քոլեջ
@hy
كلية طب نيويورك
@ar
نیویورک طیب کالجی
@azb
کالج پزشکی نیویورک
@fa
ニューヨーク医科大学
@ja
纽约医学院
@zh
altLabel
Homeopathic Medical College of the State of New York
@en
New York Homeopathic Medical College
@en
New York Med
@en
كليه طب نيويورك
@ar
prefLabel
Coleg Meddygol Efrog Newydd
@cy
New York Medical College
@en
New York Medical College
@fr
New York Medical College
@sv
Նյու Յորքի բժշկական քոլեջ
@hy
كلية طب نيويورك
@ar
نیویورک طیب کالجی
@azb
کالج پزشکی نیویورک
@fa
ニューヨーク医科大学
@ja
纽约医学院
@zh
P2643
P214
P244
P6366
P646
P131
P140
P154
P1771
P2002
nymedcollege
P2003
nymedcollege
P2013
nymedcollege
P213
0000 0001 0728 151X